Staining and Computerized Viedo Microscopy for Apoptosis

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: 1 R43 CA65323-1,
Agency Tracking Number: 24919
Amount: $62,694.00
Phase: Phase I
Program: SBIR
Awards Year: 1994
Solicitation Year: N/A
Solicitation Topic Code: N/A
Solicitation Number: N/A
Small Business Information
Oncor, Inc.
209 Perry Parkway, Suite 7, Gaithersburg, MD, 20877
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 William James
 (301) 963-3500
Business Contact
Phone: () -
Research Institution
Normal cell death regulates tumor and normal tissue kinetics, and its suppression may beassociated with prognosis and diagnosis of cancer. Apoptosis is the normal physiological process ofselective cell elimination entailing preprogrammed responses to physiological inducers and to a widespectrum of chemotherapeutic drugs. A molecular hallmark of apoptosis is that genomic DNA isfragmented and remains inside the nucleus. For staining 3'-OH ends of the DNA strand breaks in situ,terminal deoxynucleotidyl transferase (TdT) and an affinity-tagged nucleotide are applied directly to amicroscope slide. The chain is extended, and then a detectable antibody conjugate is bound. The PhaseI aims to significantly advance the technology for in situ measurement of apoptosis by (1) developingfaster and more sensitive methods of conferring color on DNA strand breaks in situ, and (2) usingcomputerized data acquisition, digital confocal microscopy, and color image analysis to very rapidlytranslate staining into a quantitative apoptotic labeling index that is directly proportional to tumor cellkinetic rate. In Phase II research, the potential clinical utility of applying this system to answer medicalquestions about cancer treatment, diagnosis and prognosis will be assessed.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government